Most Cited Papers In Last Two Years

Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

NFE2L2 and ferroptosis resistance in cancer therapy

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

Ferroptosis-related signaling pathways in cancer drug resistance

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

The role and clinical applications of exosomes in cancer drug resistance

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

The epigenetic mechanisms involved in the treatment resistance of glioblastoma

Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

Lactylation: a novel driver of drug resistance in the tumor microenvironment

The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy

Acquired resistance to molecularly targeted therapies for cancer

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers